v3.25.2
Earnings (Loss) per Common Share (Tables)
 6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings (Loss) Per Common Share
The following tables set forth the computation of the Company's basic and diluted earnings (loss) per common share:
Three Months Ended June 30,Six Months Ended June 30,
(in thousands except per share amounts)2025202420252024
Numerator:
Net income$10,879 $994 $19,147 $6,187 
Less: Dividends and accretion attributable to redeemable senior preferred stockholders— (18,565)— (31,227)
Less: Return on redeemable NCI— (58)— (639)
Net income (loss) attributable to common stockholders$10,879 $(17,629)$19,147 $(25,679)
Weighted average shares outstanding(1)
78,981 77,736 78,878 77,878 
Effect of dilutive potential common shares856 — 1,090 — 
Adjusted Weighted average shares outstanding79,837 77,736 79,968 77,878 
Basic Earnings (loss) per common share$0.14 $(0.23)$0.24 $(0.33)
Diluted Earnings (loss) per share$0.14 $(0.23)$0.24 $(0.33)
(1)For the three and six months ended June 30, 2024, the weighted-average common shares outstanding includes 1,803,841 warrants. These shares of common stock had an exercise price of $0.001 and were exercised on January 14, 2025. The warrants are considered to be equity contracts indexed in the Company's own shares and therefore were recorded at their inception date relative fair value and are included in additional paid-in capital on the Company's Unaudited Consolidated Balance Sheets.
Schedule of Antidilutive Securities Anti-dilutive securities that were excluded from the Company's earnings (loss) per common share are as follows:
Three Months Ended June 30,Six Months Ended June 30,
(in thousands)2025202420252024
Restricted stock awards(1)
26 889 — 946 
Liability-classified restricted stock units— — — — 
Outstanding stock option awards(1)
— 866 — 865 
Total26 1,755 — 1,811 
(1)Granted under the 2018 Plan.